159938 医药
已收盘 09-04 15:00:00
资讯
新帖
简况
礼邦医药-BH股获纳入港股通及恒生综合指数
同花顺 · 40分钟前
礼邦医药-BH股获纳入港股通及恒生综合指数
礼邦医药-B(09637)H股获纳入港股通及恒生综合指数
智通财经 · 43分钟前
礼邦医药-B(09637)H股获纳入港股通及恒生综合指数
纽欧申医药完成逾8000万美元的B轮超额融资
经纬创投 · 12:19
纽欧申医药完成逾8000万美元的B轮超额融资
劲方医药-B存仓市值总计19.55亿港元 股东将4373.09万股股票存入渣打银行(香港)
同花顺 · 09:11
劲方医药-B存仓市值总计19.55亿港元 股东将4373.09万股股票存入渣打银行(香港)
劲方医药-B(02595)存仓市值总计19.55亿港元 股东将4373.09万股股票存入渣打银行(香港)
智通财经 · 08:34
劲方医药-B(02595)存仓市值总计19.55亿港元 股东将4373.09万股股票存入渣打银行(香港)
劲方医药-B(02595)9月3日斥资54.64万港元回购2万股
智通财经 · 09-03 19:21
劲方医药-B(02595)9月3日斥资54.64万港元回购2万股
普莱医药冲刺港股：上半年净亏8524万 陈育新控制36%股权
雷递 · 09-03 19:04
普莱医药冲刺港股：上半年净亏8524万 陈育新控制36%股权
同源康医药-B午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌
同花顺 · 09-03 14:51
同源康医药-B午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌
同源康医药-B午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌
同花顺 · 09-03 14:48
同源康医药-B午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌
港股异动 | 同源康医药-B(02410)午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌
智通财经 · 09-03 14:30
港股异动 | 同源康医药-B(02410)午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌
沃生医药完成 1500 万美元新一轮融资 |【经纬低调新闻】
经纬创投 · 09-03 11:52
沃生医药完成 1500 万美元新一轮融资 |【经纬低调新闻】
普莱医药冲刺港股：上半年净亏8524万 陈育新控制36%股权
雷递网 · 09-03 09:09
普莱医药冲刺港股：上半年净亏8524万 陈育新控制36%股权
倒计时5天｜科创出海，药启新程·2026上海国际医药健康创新与资本大会暨第15届医药CEO论坛
国泰君安证券研究 · 09-03 06:00
倒计时5天｜科创出海，药启新程·2026上海国际医药健康创新与资本大会暨第15届医药CEO论坛
股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会会议材料》
证券之星 · 09-03 02:34
股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会会议材料》
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告》
证券之星 · 09-03 02:24
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告》
劲方医药-B回购H股39,000股 耗资约107.63万港元
同花顺 · 09-02 20:39
劲方医药-B回购H股39,000股 耗资约107.63万港元
劲方医药-B9月2日斥资107.63万港元回购3.9万股
同花顺 · 09-02 19:10
劲方医药-B9月2日斥资107.63万港元回购3.9万股
劲方医药-B(02595)9月2日斥资107.63万港元回购3.9万股
智通财经 · 09-02 19:06
劲方医药-B(02595)9月2日斥资107.63万港元回购3.9万股
迪哲医药二度递表港交所：上半年亏损超2亿，“小众靶点”天花板与现金流双重压力并存
蓝鲸财经 · 09-02 15:46
迪哲医药二度递表港交所：上半年亏损超2亿，“小众靶点”天花板与现金流双重压力并存
港股开盘｜港股低开；医药股逆市走强；联想涨逾2%
港股开盘 · 09-02 09:23
港股开盘｜港股低开；医药股逆市走强；联想涨逾2%
暂无数据
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"医药","latestPrice":0.643,"timestamp":1788505428000,"preClose":0.644,"halted":0,"volume":40600000,"delay":0,"changeRate":-0.0016,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.001,"latestTime":"09-04 15:00:00","open":0.644,"high":0.649,"low":0.64,"amount":26213300,"amplitude":0.014,"askPrice":0.644,"askSize":1261,"bidPrice":0.643,"bidSize":422,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":0.644,"symbolType":"fund","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":0.708,"lowLimit":0.58,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.032436,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159938/tweets","defaultTab":"tweets","newsList":[{"id":"2664337382","title":"礼邦医药-BH股获纳入港股通及恒生综合指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2664337382","media":"同花顺","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664337382?lang=zh_cn&edition=full","pubTime":"2026-09-04 21:37","pubTimestamp":1788529020,"startTime":"0","endTime":"0","summary":"礼邦医药-B(09637)公布，据港股通的相关安排及调整，公司H股获纳入港股通合资格证券名单，将自2026年9月7日(星期一)起生效。自生效日起，中国内地的合资格投资者可透过港股通相关机制直接买 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260904/c679621413.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260904/c679621413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664332059","title":"礼邦医药-B(09637)H股获纳入港股通及恒生综合指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2664332059","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664332059?lang=zh_cn&edition=full","pubTime":"2026-09-04 21:34","pubTimestamp":1788528840,"startTime":"0","endTime":"0","summary":"H股获纳入港股通乃基于其获纳入恒生综合指数。根据恒生指数有限公司于2026 年8月21日公布的截至2026年6月30日的恒生指数系列季度检讨结果，H股获纳入恒生综合指数成份股，有关变动已于2026年9月4日(星期五)收市后实施，并将自 2026年9月7日(星期一)起生效。董事会认为，H股获纳入港股通及恒生综合指数，反映了资本市场对公司价值及长期发展前景的认可，并将有助于进一步扩大公司的投资者基础，提升H股的交易流动性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","FLHK","BK1191","09939","09637","BK1574","HSCI","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664369163","title":"纽欧申医药完成逾8000万美元的B轮超额融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2664369163","media":"经纬创投","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664369163?lang=zh_cn&edition=full","pubTime":"2026-09-04 12:19","pubTimestamp":1788495540,"startTime":"0","endTime":"0","summary":"综述近日，纽欧申医药宣布完成逾8000万美元的B轮超额融资，经纬创投参与投资。三大核心项目均处于临床阶段目前，纽欧申医药已构建起涵盖小分子创新药的差异化研发管线，三大核心项目均处于临床开发阶段：NS-079 · 非致幻性5-HT2A受体部分激动剂开拓难治性抑郁症新路径NS-079的核心作用机制是神经可塑性调节。目前，NS-079已在澳洲启动首次人体试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3ODk5OTEzOA==&mid=2962188653&idx=2&sn=9648168cc3abbfe551d228585ca0897a&chksm=abf451d91501b032eafed6bf17710a8b01a3f275a7235b49ed55199b530f45fcd590769d04a4&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["159938","BK1515","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664538867","title":"劲方医药-B存仓市值总计19.55亿港元 股东将4373.09万股股票存入渣打银行(香港)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664538867","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664538867?lang=zh_cn&edition=full","pubTime":"2026-09-04 09:11","pubTimestamp":1788484260,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，9月3日，劲方医药-B(02595)出现存仓异动，存仓市值总计19.55亿港元，占比19.65%。该公司股东将4373.09万股股票存入渣打银行(香港)，持股比例增加12.44%。劲方医药 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260904/c679592276.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260904/c679592276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388377","title":"劲方医药-B(02595)存仓市值总计19.55亿港元 股东将4373.09万股股票存入渣打银行(香港)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388377","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664388377?lang=zh_cn&edition=full","pubTime":"2026-09-04 08:34","pubTimestamp":1788482051,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，9月3日，劲方医药-B(02595)出现存仓异动，存仓市值总计19.55亿港元，占比19.65%。该公司股东将4373.09万股股票存入渣打银行(香港)，持股比例增加12.44%。劲方医药此前发布公告，GFH375已进入一线治疗KRAS G12D突变型晚期非小细胞肺癌(NSCLC)的II期研究，包括单药疗法、联合EGFR单抗(西妥昔单抗)或联合化疗(培美曲塞)三种治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK1515","02595","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664879974","title":"劲方医药-B(02595)9月3日斥资54.64万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664879974","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664879974?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:21","pubTimestamp":1788434461,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2026年9月3日斥资54.64万港元回购2万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","159938","02595","BK1574","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664052418","title":"普莱医药冲刺港股：上半年净亏8524万 陈育新控制36%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664052418","media":"雷递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664052418?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:04","pubTimestamp":1788433440,"startTime":"0","endTime":"0","summary":"雷递网 雷建平 9月3日普莱医药(江苏)股份有限公司日前更新招股书，准备在港交所上市。招股书显示，普莱医药2024年、2025年营收为519万元、333万元，期内亏损为1.58亿元、1.42亿元；2026年上半年营收为219万元，期内亏损为8524万元。截至2026年6月30日，普莱医药持有的现金及现金等价物为3405万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzQ5NjIyMQ==&mid=2661683474&idx=7&sn=bca14730937a2fe78c3d448dbc9cb9aa&chksm=bcacb7db309c0c1c9df6205ee975a2573ec5da079fc40206fed8c142a1526610a6c9b77b7e99&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664824914","title":"同源康医药-B午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664824914","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664824914?lang=zh_cn&edition=full","pubTime":"2026-09-03 14:51","pubTimestamp":1788418260,"startTime":"0","endTime":"0","summary":"9月3日，同源康医药-B(02410.HK)午后涨超9%。截至发稿，涨8.80%，报6.06港元，成交额1512.29万港元。消息面上，同源康医药近日宣布，公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260903/c679562871.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260903/c679562871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664824333","title":"同源康医药-B午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664824333","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664824333?lang=zh_cn&edition=full","pubTime":"2026-09-03 14:48","pubTimestamp":1788418080,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410)午后涨超9%。截至发稿，涨8.80%，报6.06港元，成交额1512.29万港元。消息面上，同源康医药近日宣布，公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片(TY-9591， ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260903/c679562830.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260903/c679562830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664824858","title":"港股异动 | 同源康医药-B(02410)午后涨超9% EGFR-TKI氘申艾替尼获批一线治疗晚期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664824858","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664824858?lang=zh_cn&edition=full","pubTime":"2026-09-03 14:30","pubTimestamp":1788417020,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B午后涨超9%。消息面上，同源康医药近日宣布，公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片已正式获得中国国家药品监督管理局批准附条件上市，适应症为具有表皮生长因子受体外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。同源康预计收取7亿元人民币现金首付款及股份认购款，以及最高20.6亿元人民币的注册里程碑付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1515","VXUS","BK1574","02410","KCAI","09939","BK1161","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875595","title":"沃生医药完成 1500 万美元新一轮融资 |【经纬低调新闻】","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875595","media":"经纬创投","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664875595?lang=zh_cn&edition=full","pubTime":"2026-09-03 11:52","pubTimestamp":1788407520,"startTime":"0","endTime":"0","summary":"综述聚焦中枢神经退行性疾病的平台型生物技术企业苏沃生医药，完成总额1500万美元新一轮融资。本轮融资由经纬创投领投。经纬观点作为领投方，经纬创投是沃生最大的外部机构股东之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3ODk5OTEzOA==&mid=2962188635&idx=2&sn=8af16f84410e03d3b16112f593d5b2f7&chksm=abb4a57eea7e930e64d4bf3ee886a2044bfba6ac7da17ac0d6273485f22df6fd7dbd6180cdb4&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1161","BK1515","BK1574","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664900840","title":"普莱医药冲刺港股：上半年净亏8524万 陈育新控制36%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664900840","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664900840?lang=zh_cn&edition=full","pubTime":"2026-09-03 09:09","pubTimestamp":1788397741,"startTime":"0","endTime":"0","summary":"普莱医药(江苏)股份有限公司（简称：“普莱医药”）日前更新招股书，准备在港交所上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260903/6392402332203885668434286.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260903/6392402332203885668434286.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35053/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["09939","BK1161","BK4588","BK1574","BK4585","159938","VXUS","KCAI","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664517826","title":"倒计时5天｜科创出海，药启新程·2026上海国际医药健康创新与资本大会暨第15届医药CEO论坛","url":"https://stock-news.laohu8.com/highlight/detail?id=2664517826","media":"国泰君安证券研究","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664517826?lang=zh_cn&edition=full","pubTime":"2026-09-03 06:00","pubTimestamp":1788386400,"startTime":"0","endTime":"0","summary":"重要提醒本订阅号所载内容仅面向国泰海通证券研究服务签约客户。因本资料暂时无法设置访问限制，根据《证券期货投资者适当性管理办法》的要求，若您并非国泰海通证券研究服务签约客户，为保证服务质量、控制投资风险，还请取消关注，请勿订阅、接收或使用本订阅号中的任何信息。法律声明本公众订阅号为国泰海通证券股份有限公司 研究所依法设立、独立运营的唯一官方订阅号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["research"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MzEwMDEzNQ==&mid=2650541224&idx=1&sn=96b854d0fb78e4b940add5b94cc33930&chksm=89e6fb4c40a99915c57ffe22214f7bda91fc77d8e4f1bbad8d570060cbd46cc5946410d99e25&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1161","BK1515","159982","BK1574","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664845077","title":"股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会会议材料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845077?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:34","pubTimestamp":1788374054,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，大参林报收于18.08元，下跌1.79%，换手率0.57%，成交量6.51万手，成交额1.19亿元。公司公告汇总大参林医药集团股份有限公司2026年第二次临时股东会会议材料大参林拟通过员工持股平台广州集芸智投资服务合伙企业间接参股安徽大参林药业有限公司和新疆大参林医药连锁有限公司。公司放弃相关优先权利，本次交易不影响合并报表范围及控制权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0185","BK0114","159938","BK1515","09939","BK1574","BK0209","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664984574","title":"股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664984574","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664984574?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:24","pubTimestamp":1788373453,"startTime":"0","endTime":"0","summary":"公司公告汇总鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告鲁商福瑞达医药股份有限公司控股股东山东省商业集团有限公司与山东省国有资产投资控股有限公司于2026年8月6日签署《股份转让协议》，拟转让公司50,828,500股股份，转让价格为5.384元/股，转让对价273,660,644.00元。转让后，山东省商业集团有限公司持股比例由51.62%降至46.62%，山东国投持股比例为5.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0273","159938","09939","600223","BK0188","BK1515","BK1161","BK0229","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381432","title":"劲方医药-B回购H股39,000股 耗资约107.63万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381432","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664381432?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:39","pubTimestamp":1788352740,"startTime":"0","endTime":"0","summary":"劲方医药-B(02595.HK)于2026年9月2日在香港联合交易所回购H股39,000股，每股最高回购价HKD27.74，每股最低回购价HKD27.4，付出价格总额HKD1,076,308。回购股份被持作库存股份，占有关事件前 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260902/c679539334.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260902/c679539334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664781630","title":"劲方医药-B9月2日斥资107.63万港元回购3.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664781630","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664781630?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:10","pubTimestamp":1788347400,"startTime":"0","endTime":"0","summary":"劲方医药-B(02595)发布公告，于2026年9月2日，该公司斥资107.63万港元回购3.9万股。 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260902/c679535087.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260902/c679535087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815269","title":"劲方医药-B(02595)9月2日斥资107.63万港元回购3.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815269","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664815269?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:06","pubTimestamp":1788347190,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2026年9月2日，该公司斥资107.63万港元回购3.9万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","159938","09939","BK1515","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894762","title":"迪哲医药二度递表港交所：上半年亏损超2亿，“小众靶点”天花板与现金流双重压力并存","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894762","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664894762?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:46","pubTimestamp":1788335190,"startTime":"0","endTime":"0","summary":"目前，迪哲医药两款核心产品舒沃哲和高瑞哲均已进入国家医保目录。截至2026年中，迪哲医药无控股股东和实际控制人。就在9月1日，迪哲医药发布公告称，公司与阿斯利康签署《许可协议》，授予阿斯利康在全球范围内独家开发、商业化舒沃哲的权利。不过，市场依然对两款产品的天花板存在争议。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788335043232116627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IPOS","BK1515","BK4588","159938","BK1574","BK4585","159399","SPHQ","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144703788","title":"港股开盘｜港股低开；医药股逆市走强；联想涨逾2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144703788","media":"港股开盘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144703788?lang=zh_cn&edition=full","pubTime":"2026-09-02 09:23","pubTimestamp":1788312190,"startTime":"0","endTime":"0","summary":"核心科网股表现分化：受AI服务器需求利好刺激，联想集团逆势上涨逾2%，其余多数龙头回调0.2%–1%不等。盘面异动方面，数据中心概念新意网高开近7%领跑；医药股获资金青睐，先声药业、云顶新耀等延续强势；黄金股则受金价走弱影响集体下挫，万物云大跌近7%拖累物业管理板块。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","HK0000320223.HKD","LU0890818403.SGD","LU0310800965.SGD","LU0572939691.SGD","LU1366334578.USD","TCHI","VXUS","80992","09939","BK4585","IE0032431581.USD","LU0370786039.SGD","LU1046422090.SGD","BK1607","LU0128525689.USD","LU0029875118.USD","LU0128522157.USD","LU2242644610.SGD","BK1193","159938","BK1161","HK0000320264.USD","HK0000306685.HKD","LNVGY","LU0791591158.USD","BK1515","LU1366334651.USD","LU1267930227.SGD","BK4588","LU0791590937.USD","LU0972618739.USD","00992","IE00B0JY6N72.USD","LU0264606111.USD","IE0003895053.USD","LU0320764755.SGD","LU0862451753.SGD","LU0049112450.USD","LU0048580855.USD","LU0543330483.HKD","LU1785774172.SGD","IE0034224299.USD","KCAI","LU0052756011.USD","LU0572940350.SGD","LU0672654166.SGD","03441","BK1526","LU1235295612.USD","BK1574","LU0862451837.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788531413286,"stockEarnings":[{"period":"1week","weight":-0.0213},{"period":"1month","weight":-0.0123},{"period":"3month","weight":0.122},{"period":"6month","weight":0.0063},{"period":"1year","weight":-0.1448},{"period":"ytd","weight":-0.0077}],"compareEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.0313},{"period":"3month","weight":-0.0213},{"period":"6month","weight":-0.0442},{"period":"1year","weight":0.0337},{"period":"ytd","weight":-0.0067}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药,159938,医药股票,医药股票老虎,医药股票老虎国际,医药行情,医药股票行情,医药股价,医药股市,医药股票价格,医药股票交易,医药股票购买,医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}